Morphine-like Synthetic Opioid Placed in Schedule I Following UN Action

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Scheduling Actions

Morphine-like Synthetic Opioid Placed in Schedule I Following UN Action

Ken Baumgartner

December 13, 2017 at 20:08:38 ET

Following international scheduling by a United Nations commission, the synthetic opioid drug MT-45 has been placed in Schedule I of the Controlled Substances Act (82 Fed. Reg. 58557; Dec. 13, 2017). This compound is a piperazine derivative structurally unrelated to most other opioids. It has been offered on the internet as a purportedly “legal” opioid. Deaths and nonfatal overdose... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Morphine-like Synthetic Opioid Placed in Schedule I Following UN Action

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT